LABORATORY NEWS
-
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity And Higher Cell Recovery
Parse Biosciences, a QIAGEN company and the leading provider of scalable and accessible single-cell sequencing solutions today announced the launch of the new Evercode Whole Transcriptome v4 product line, delivering expanded scalability, higher sensitivity and a simplified workflow for single-cell RNA sequencing.
- DEXIS Advances Digital Dentistry With Enhanced Lab-To-Clinic Workflow Solutions
- Breath Diagnostics, Inc. Receives FDA Breakthrough Device Designation For OneBreath™ Platform To Aid Pre-Operative Pneumonia Risk Assessment
- Meridian Life Science Expands Ambient-Stable NGS Portfolio With The Launch Of A Lyophilized Enzymatic DNA Fragmentation Kit
- Project Santa Fe Foundation And Virchow Medical Announce First-Of-Its-Kind Partnership To Advance Proactive Analytics In Clinical Laboratory Medicine
ARCHIVED NEWSLETTER
- 02.10.26 -- Why Use Total Organic Carbon Analysis For Cleaning Validation?
- 01.20.26 -- Rats Behind The Wheel: The Right Preclinical Way To Investigate Drug Effects On Driving?
- 01.06.26 -- To Fight Cancer, Gene Editing Needs To Solve Its Delivery Problem
- 12.23.25 -- Why Do So Few Cell Therapies Make The Leap From Lab To GMP?
- 12.09.25 -- What You Should Know About USP's Bioassay Updates